HK1028016A1 - Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis - Google Patents

Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis

Info

Publication number
HK1028016A1
HK1028016A1 HK00107213A HK00107213A HK1028016A1 HK 1028016 A1 HK1028016 A1 HK 1028016A1 HK 00107213 A HK00107213 A HK 00107213A HK 00107213 A HK00107213 A HK 00107213A HK 1028016 A1 HK1028016 A1 HK 1028016A1
Authority
HK
Hong Kong
Prior art keywords
drugs
acid derivatives
removal promotion
pain remission
urinary lithiasis
Prior art date
Application number
HK00107213A
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Hideyuki Muranaka
Harunobu Mukaiyama
Akihito Hirabayashi
Masaaki Sato
Masuo Akahane
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of HK1028016A1 publication Critical patent/HK1028016A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK00107213A 1997-07-25 2000-11-13 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis HK1028016A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23323997 1997-07-25
PCT/JP1998/003163 WO1999005090A1 (fr) 1997-07-25 1998-07-15 Derives d'acide aminoethylphenoxyacetique et medicaments qui reduisent la douleur et favorisent la suppression des calculs dans la lithiase urinaire

Publications (1)

Publication Number Publication Date
HK1028016A1 true HK1028016A1 (en) 2001-02-02

Family

ID=16951956

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107213A HK1028016A1 (en) 1997-07-25 2000-11-13 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis

Country Status (29)

Country Link
US (1) US6399660B1 (de)
EP (1) EP1002791B1 (de)
JP (1) JP4002391B2 (de)
KR (1) KR100545473B1 (de)
CN (1) CN1137877C (de)
AR (1) AR013241A1 (de)
AT (1) ATE280146T1 (de)
AU (1) AU754579B2 (de)
BR (1) BR9811483B1 (de)
CA (1) CA2298493C (de)
CO (1) CO4970779A1 (de)
CZ (1) CZ300389B6 (de)
DE (1) DE69827137T2 (de)
ES (1) ES2231996T3 (de)
HK (1) HK1028016A1 (de)
HU (1) HUP0004055A3 (de)
ID (1) ID24062A (de)
IL (1) IL133863A0 (de)
MY (1) MY126743A (de)
NO (1) NO315422B1 (de)
NZ (1) NZ502366A (de)
PE (1) PE99899A1 (de)
PL (1) PL191864B1 (de)
PT (1) PT1002791E (de)
RU (1) RU2196130C2 (de)
SA (1) SA98190661B1 (de)
TW (1) TW418184B (de)
WO (1) WO1999005090A1 (de)
ZA (1) ZA986580B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4212771B2 (ja) 1998-04-14 2009-01-21 キッセイ薬品工業株式会社 ２−メチルプロピオン酸誘導体および当該誘導体を含有する医薬組成物
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
DE60024053T2 (de) * 1999-01-21 2006-07-20 Kissei Pharmaceutical Co., Ltd., Matsumoto Kristall-polymorphismus von derivaten der aminoethylphenoxyessigsäure
CA2479254A1 (en) * 2002-03-22 2003-10-02 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for renal disease
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
DE10333569A1 (de) * 2003-07-23 2005-02-17 Z & J Technologies Gmbh Einrichtung zur Verteilung von Schüttgut in wenigstens zwei oberhalb der Gicht eines Hochofens angeordnete Bunker
JP4843313B2 (ja) * 2004-02-12 2011-12-21 キッセイ薬品工業株式会社 食道の運動障害を伴う疾患の予防または治療用医薬組成物
WO2007004639A1 (ja) * 2005-07-06 2007-01-11 Daiichi Fine Chemical Co., Ltd. 光学活性エリスロ-β-アミノアルコールの製法
AU2006285963A1 (en) * 2005-08-29 2007-03-08 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
ES2302447B1 (es) * 2006-10-20 2009-06-12 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ES2195021T3 (es) * 1995-11-30 2003-12-01 Kissei Pharmaceutical Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis.
AU4320297A (en) * 1996-09-26 1998-04-17 Kissei Pharmaceutical Co. Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives

Also Published As

Publication number Publication date
ATE280146T1 (de) 2004-11-15
EP1002791A1 (de) 2000-05-24
EP1002791B1 (de) 2004-10-20
HUP0004055A2 (hu) 2001-04-28
SA98190661B1 (ar) 2006-09-09
RU2196130C2 (ru) 2003-01-10
KR20010022124A (ko) 2001-03-15
HUP0004055A3 (en) 2001-10-29
AU754579B2 (en) 2002-11-21
CZ2000272A3 (cs) 2000-05-17
PL191864B1 (pl) 2006-07-31
DE69827137T2 (de) 2006-03-09
ID24062A (id) 2000-07-06
PE99899A1 (es) 1999-11-11
EP1002791A4 (de) 2001-09-12
CN1137877C (zh) 2004-02-11
MY126743A (en) 2006-10-31
AU8241998A (en) 1999-02-16
NO20000371L (no) 2000-01-25
PT1002791E (pt) 2005-01-31
US6399660B1 (en) 2002-06-04
TW418184B (en) 2001-01-11
CO4970779A1 (es) 2000-11-07
BR9811483B1 (pt) 2009-01-13
AR013241A1 (es) 2000-12-13
PL338234A1 (en) 2000-10-09
ZA986580B (en) 1999-02-04
BR9811483A (pt) 2000-09-19
IL133863A0 (en) 2001-04-30
KR100545473B1 (ko) 2006-01-24
ES2231996T3 (es) 2005-05-16
CA2298493C (en) 2008-03-18
DE69827137D1 (de) 2004-11-25
WO1999005090A1 (fr) 1999-02-04
CN1265091A (zh) 2000-08-30
NO20000371D0 (no) 2000-01-25
CA2298493A1 (en) 1999-02-04
JP4002391B2 (ja) 2007-10-31
NZ502366A (en) 2004-12-24
CZ300389B6 (cs) 2009-05-06
NO315422B1 (no) 2003-09-01

Similar Documents

Publication Publication Date Title
IL121651A0 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
PL307463A1 (en) Pharmaceutical agent especially for inhibiting osteoporosis and lowering cholesterol level in blood serum
EP1024130A4 (de) Biphenyl-5-alkansäure-derivate und ihre anwendung
HK1029914A1 (en) Device and pharmaceutical agent for treatment of dysmenorrhea
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
HUP0001286A3 (en) Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs
EP1216980A4 (de) Carbonsäurederivate und medikamente, die diese enthalten
PL331374A1 (en) Method of selectively obtaining acetic acid and catalyst suitable for use in that method
IL131229A0 (en) Compounds and methods for therapeutic intervention in preventing diabetic complications
IL133863A0 (en) Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
HUP9902451A3 (en) Process and device for promotion of regeneration of organized tissues
HUP0100597A3 (en) Hydroxamic and carboxylic acid derivatives
HUP0004510A3 (en) Process for obtaining l-dihydroorotic acid and use thereof
GB2333042B (en) Colonic delivery of weak acid drugs
GB9911071D0 (en) Hydroxamic and carboxylic acid derivatives
HUP0102073A3 (en) Hydroxamic and carboxylic acid derivatives and medicaments containing them
GB9911075D0 (en) HYdroxamic and carboxylic acid derivatives
GB9911073D0 (en) Hydroxamic and carboxylic acid derivatives
AU5319400A (en) Molecules for disease detection and treatment
AU2713797A (en) Depigmentating agent in the treatment of melasma
AU5457300A (en) Surface stabilized microbubbles for use in ultrasound contrast and drug deliveryagents
AU4068500A (en) Increased fertility and improved fetal development drug
GB9819572D0 (en) Hydroxamic and carboxylic acid derivatives
GB9819570D0 (en) Hydroxamic and carboxylic acid derivatives
GB9813932D0 (en) Hydroxamic and carboxylic acid derivatives

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130715